Adicet Bio, Inc.
ACET
$9.64
-$0.09-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.88M | 20.00M | 22.99M | 23.61M | 25.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.71M | 113.80M | 122.12M | 120.97M | 126.17M |
| Operating Income | -103.71M | -113.80M | -122.12M | -120.97M | -126.17M |
| Income Before Tax | -98.83M | -108.83M | -116.80M | -115.01M | -118.64M |
| Income Tax Expenses | 143.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -98.97 | -108.83 | -116.80 | -115.01 | -118.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.97M | -108.83M | -116.80M | -115.01M | -118.64M |
| EBIT | -103.71M | -113.80M | -122.12M | -120.97M | -126.17M |
| EBITDA | -98.12M | -107.76M | -115.73M | -114.44M | -119.62M |
| EPS Basic | -11.53 | -15.03 | -18.10 | -20.22 | -20.87 |
| Normalized Basic EPS | -7.20 | -9.39 | -11.31 | -12.64 | -13.04 |
| EPS Diluted | -11.53 | -15.03 | -18.10 | -20.22 | -20.87 |
| Normalized Diluted EPS | -7.20 | -9.39 | -11.31 | -12.64 | -13.04 |
| Average Basic Shares Outstanding | 37.55M | 32.50M | 27.44M | 22.76M | 22.74M |
| Average Diluted Shares Outstanding | 37.55M | 32.50M | 27.44M | 22.76M | 22.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |